Details
For biopharma operating in today’s high-pressure clinical development landscape, with limited resources and budget, and driven by the desire to meet the next critical inflection point as quickly as possible, the margin for error is razor thin. One misstep in vendor selection and oversight can waste valuable investment money, compromise compliance, or derail your development programme entirely. But with the right vendor oversight, you will maximise your return on investment.
This webinar dives into the real-world consequences of getting vendor oversight wrong, what can then be done to rescue development programmes, and more importantly, how to get it right the first time! Anchored around real case studies, our experts will explore where things went wrong and why, and how proactive strategies can help avoid or recover from the same pitfalls.
Expect practical insights drawn from fast-moving scientific environments in early development, challenges in pivotal clinical trials and post-marketing complexities — all with a focus on clinical success through smarter vendor oversight.
Key Themes & Takeaways
1. Compliance: Navigating Oversight in a highly Regulated World
- Learn how inadequate oversight can quickly lead to regulatory breaches or GxP deviations
- Discover how to instil and maintain robust processes
- Explore how tailored vendor selection and management upfront prevents costly downstream issues
- Recognise unnecessary spend and avoid investing in non-essential systems or services
- Learn the signs of financial leakage in vendor partnerships and how to plug them early
3. Outcomes and Optimisation: Delivering the Data to enable timely Decision-Making and Optimise your Label
- Understand the impact of poor data collection and input: because “rubbish in” means “rubbish out”
- Embed clarity, accountability and performance metrics from the outset
- Adapt swiftly to changing circumstances, driven by emerging data and / or medical landscape
Why Attend?
This isn’t just another discussion on regulatory compliance when conducting vendor management. We will provide insights into how oversight can either enable success or quietly sabotage your asset. If you're about to embark on a development programme, scaling operations, or dealing with current vendor challenges, this session will give you the clarity, confidence, and course-correction strategies you need.
Who Should Attend?
- Founders, CEOs, CSOs, CMOs plus Clinical Operations Leads and Programme Directors at BioPharma companies
- Regulatory, PV, QA and Finance leaders seeking stronger oversight controls
- Investors in Biopharma
Registration
Register to join live or receive the recording after.
